How a Drugmaker Profited by Slow-Walking a Promising H.I.V. Therapy
How a Drugmaker Profited by Slow-Walking a Promising H.I.V. Therapy
www.nytimes.com How a Drugmaker Profited by Slow-Walking a Promising H.I.V. Therapy
Gilead delayed a new version of a drug, allowing it to extend the patent life of a blockbuster line of medications, internal documents show.
You're viewing a single thread.
10
comments
Some actual Lex Luther level evil. I remember a scene in the old Justice League or Superman cartoon. Someone walks up to him and he hands off a tablet and says something like, here’s the cure for cancer now break it up in to 10 treatments and charge $1k per dose. Repugnant in a cartoon and worse in reality.
Well being that my surgery cost 10 times this, 10k is a bargain.
You've viewed 10 comments.